RECURSION PHARMACEUTICALS, INC. (RXRX)
1 Item 5.02 filing since 2026-11-02. Nasdaq. Biological Products, (No Diagnostic Substances). State: UT.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 0 | 2026-11-02 | — | — | subscribers | — | RECURSION PHARMACEUTICALS, INC.: Item 5.02 filing |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works